Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 28, 2015British Journal of CancerOpen Access

Utility of pre-treatment neutrophil–lymphocyte ratio and platelet–lymphocyte ratio as prognostic factors in breast cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

CKC-H KohHospital Tengku Ampuan AfzanNBNirmala Bhoo‐PathyUniversity of MalayaKNK.P. NgUniversity Malaya Medical Centre

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Koh et al. (2015) studied this question.

synapsesocial.com/papers/6a809f057b6b010bd4701995https://doi.org/10.1038/bjc.2015.183
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Hallmarks of Cancer: The Next Generation2011 · 68,085 citations
  2. 2Circulating Biomarkers of One-Carbon Metabolism in Relation to Renal Cell Carcinoma Incidence and Survival2014 · 121 citations
  3. 3Breast cancer incidence and mortality trends in an affluent population: Marin County, California, USA, 1990–19992002 · 62 citations
  4. 4Neutrophil–lymphocyte ratio predicts overall and recurrence‐free survival after liver transplantation for hepatocellular carcinoma2012 · 75 citations
  5. 5Lack of Prognostic Value of Blood Parameters in Patients Receiving Adjuvant Radiotherapy for Breast Cancer2014 · 56 citations